Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05681234

Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma

Conditions: Liver Carcinoma

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 30
Sponsor: Affiliated Hospital of Jiangnan University

Location: China

Summary

This is a single arm study to evaluate the safety and biodistribution of 18F-labeled RD2 PET/CT Imaging in patients with small liver carcinoma.

Eligibility Criteria

Inclusion Criteria:Patients with highly suspected tumor；Patients underwent PET/CT examination within 1 week;Patients voluntarily signed informed consent;Over 18 years old, male or female.Exclusion Criteria:Pregnant women;Lactating women;Patients with impaired renal function.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05681234). StuddyBuddy aggregates publicly available trial information.